CMRA - Comera Life Sciences GAAP EPS of -$0.10 revenue of $0.14M November, 09 2023 12:16 PM Comera Life Sciences Holdings Inc. 2023-11-09 12:16:06 ET Comera Life Sciences press release ( NASDAQ: CMRA ): Q3 GAAP EPS of -$0.10. Revenue of $0.14M (-41.7% Y/Y). Comera had approximately $1.8 million in cash at September 30, 2023. For further details see: Comera Life Sciences GAAP EPS of -$0.10, revenue of $0.14M